Language

Women's Health Research

Women's Health Research Studies

Through the MultiCare Institute for Research & Innovation, women in our community have access to the latest treatment options through medical research. We rotate clinical trials for novelty medications and devices throughout the year for a wide variety of therapeutic areas including:

  • Contraception
  • Endometriosis
  • Female sexual dysfunction, libido
  • Hormone replacement therapy
  • Human papillomavirus (HPV)
  • Menopause
  • Overactive bladder
  • Uterine Fibroids
  • Vaginal infections

Principal Investigators:

Sub-Investigators:

Women's Health Studies Accepting Patients

Female Sexual Dysfunction, Libido

VI-15-01

Study Number: VI-15-01—Viveve Geneveve Treatment of the Vaginal Introitus to Evaluate Safety and Efficacy

Study Info

Principal Investigator(s): James Rice, MD

Study Coordinator: Gabbie Smith, [email protected], 253.697.4291

Uterine Fibroids

Liberty 2

Study Number: MVT-601-3002—An international Phase III randomized, double-blind, placebo-controlled efficacy and safety study to evaluate Relugolix co-administered with and without low-dose Estradoil and Norethindrone Acetate in women with heavy menstrual bleeding associated with uterine fibroids.

Study Info

Principal Investigator(s): James Rice, MD

Study Coordinator: Gabbie Smith, [email protected], 253.697.4291


ASTEROID 3

Study Number: BAYER 15787—A randomized, parallel-group, double-blind and open-label, placebo-controlled, multicenter study to assess the efficacy and safety of vilaprisan in subjects with uterine fibroids.

Study Info

Principal Investigator(s): James Rice, MD

Study Coordinator: Gabbie Smith, [email protected], 253.697.4291

Overactive Bladder & Incontinence

Allergan BOTOX Stage 2

Study Number: 1839-201-021—A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled, Single-treatment, 2-stage, Dose-finding Study Evaluating the Efficacy and Safety of BOTOX® Intravesical Instillation in Participants with Overactive Bladder and Urinary Incontinence

Study Info

Principal Investigator(s): Krista Reagan, MD

Study CoordinatorDalia Sherif, [email protected], 253-403-2698